TMT Capital Partners is a private equity general partner firm headquartered in Chicago, Illinois , United States.
MicuRx Pharmaceuticals, a developer of next-generation antibiotic, closed a $55m Series C financing from TMT Capital and others.
Read more news concerning TMT Capital Partners
A sampling of TMT Capital Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?